E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/20/2015 in the Prospect News PIPE Daily.

Versartis to conduct $75 million public offering of its common shares

Deal offers stock through bookrunners Citigroup, Credit Suisse, Cowen

By Devika Patel

Knoxville, Tenn., Jan. 20 ‑ Versartis, Inc. plans to raise $75 million in a public offering of common stock with an $11.25 million greenshoe, according to a Form S-1/A filed Tuesday with the Securities and Exchange Commission.

Citigroup, Credit Suisse and Cowen and Co. are the joint bookrunning managers. Canaccord Genuity and SunTrust Robinson Humphrey are the co-managers.

Proceeds will be used for clinical development, working capital, capital expenditures and other general corporate purposes, including acquisitions.

The endocrine-focused biopharmaceutical company is based in Redwood City, Calif.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.